Depocyt® With Sorafenib in Neoplastic Meningitis
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations
- Status
- COMPLETED
- Phase
- PHASE1
4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the Liver
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Sorafenib Added to Standard Primary Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Less Than 60 Years of Age
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib-RT Treatment for Liver Metastasis (SLIM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib in Relapsed High Grade Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
- Status
- COMPLETED
- Phase
- PHASE2